Latest Manufacturing News

Hydrix has secured a three-year contract with Singapore’s National Heart Centre to deploy the Implicity remote cardiac monitoring platform. The agreement is expected to generate about A$0.625 million, although the final value depends on patient volumes and implementation.

AML3D has secured an initial AU$0.5 million order to manufacture three high-pressure copper-nickel components for US Navy nuclear submarines. The deal moves its Ohio operation from qualification programs into paid production, although delivery, testing and commissioning remain outstanding.

Eneco Refresh has delivered its strongest profit in five years despite raw material inflation and logistics disruption, with operating cash flow and cash reserves also improving. The company now has scope to invest in automation and consider selective acquisitions, but offers no FY2027 earnings guidance or dividend.

Dyno Nobel has reaffirmed its FY26 outlook and retained its A$600 million FY28 underlying EBIT ambition, while setting a new A$800 million target for FY31. The explosives maker is positioning defence energetics, premium technology and growth in mining markets as the next leg of expansion.

Cambium Bio has secured firm commitments for a conditional A$7.1 million placement, taking its proposed funding package to A$10.85 million for the pivotal Elate Ocular Phase 3 program. Completion depends on three inter-conditional shareholder resolutions at the company’s expected November AGM.

IperionX says its GenX continuous titanium furnace processed more than 500 kilograms of powder while using substantially less power, magnesium and hydrogen than batch HAMR production. The results strengthen the case for an industrial-scale line, although further optimisation and engineering work are still required.

Talga has signed a non-binding LOI with German battery maker EAS Batteries for a potential five-year supply agreement covering Talnode graphite anode products. No volumes or purchase obligations have been agreed, with product qualification and negotiations now scheduled to run into 2027.

Li-S Energy says its Geelong lithium-sulfur production line is complete and has delivered 10Ah Power Cells to the US Army for testing. The company is targeting its first commercial battery sale in 2027, while holding A$15.6 million in cash and investments and A$9.3 million in secured grants yet to be received.

James Hardie has raised its FY27 Free Cash Flow target to at least US$600 million and expects to deliver its US$125 million cost synergy target roughly a year early. The company also outlined a 4% to 7% annual organic growth ambition above market, while targeting net leverage below 2.0x by Q2 FY28.

EBR Systems’ new Santa Clara manufacturing facility has entered the FDA’s pre-approval inspection process, marking a key regulatory step for its wireless cardiac pacing business. The company continues to expect approval by the end of 2026, but the inspection does not yet amount to clearance.

PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.

Element 25 has started early site works at its Butcherbird Expansion Project in Western Australia, preparing the ground for a planned 1.1Mtpa manganese operation. The milestone shifts the project from planning towards physical construction, although the main construction package is yet to be awarded.